The findings established Ipamorelin's defining characteristic: Growth hormone Ipamorelin produced dose-dependent GH release comparable to GHRP-6 Cortisol No significant cortisol elevation was observed with Ipamorelin, while GHRP-2 and GHRP-6 produced measurable cortisol increases Prolactin No significant prolactin elevation at GH-effective concentrations ACTH No significant ACTH stimulation, contrasting with the adrenocorticotropic effects of other GHRPs GHRP Selectivity Comparison (Preclinical Data) Compound GH Release Cortisol Effect Prolactin Effect ACTH Effect Ipamorelin Dose-dependent Minimal / none Minimal / none Minimal / none GHRP-2 Dose-dependent Moderate increase Moderate increase Moderate increase GHRP-6 Dose-dependent Moderate increase Moderate increase Moderate increase Hexarelin Strong Significant increase Significant increase Significant increase Data adapted from Raun et al

The most common side effects are gastrointestinal , such as mild nausea, bloating, or constipation, particularly in the early stages of dose adjustment
Long-term pharmacovigilance continues to monitor for any emerging signals
Consultations are available at our New York City location in Manhattan, our office in Scarsdale, or one of our offices on Long Island: Southampton, Smithtown, or Woodbury, as well as, Princeton, and Boca Raton
Adderall is a prescription drug based on a combination of amphetamine salts that has shown promising results in treating Attention Deficit Hyperactivity Disorder (ADHD)